Home / Oil and Gas / Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Published: Jul 2015 | No Of Pages: 99 | Published By: GlobalData

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015" provides an overview of Central Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Central Retinal Vein Occlusion 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Novartis AG 30
Clinical Trial Overview of Novartis AG 30
F. Hoffmann-La Roche Ltd. 31
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 31
Regeneron Pharmaceuticals, Inc. 32
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Allergan Plc 34
Clinical Trial Overview of Allergan Plc 34
Mid Atlantic Retina 35
Clinical Trial Overview of Mid Atlantic Retina 35
Jaguar Holding Company II 36
Clinical Trial Overview of Jaguar Holding Company II 36
Gene Signal International SA 37
Clinical Trial Overview of Gene Signal International SA 37
California Retina Consultants 38
Clinical Trial Overview of California Retina Consultants 38
Asociacion para Evitar la Ceguera en Mexico I.A.P. 39
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 39
Clinical Trial Overview of Top Institutes / Government 40
Shahid Beheshti University of Medical Sciences 40
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 40
Banco de Olhos de Sorocaba 41
Clinical Trial Overview of Banco de Olhos de Sorocaba 41
Centre Hospitalier Intercommunal Creteil 42
Clinical Trial Overview of Centre Hospitalier Intercommunal Creteil 42
Duke University 43
Clinical Trial Overview of Duke University 43
Eye Laser Surgery Center 44
Clinical Trial Overview of Eye Laser Surgery Center 44
Gazi University 45
Clinical Trial Overview of Gazi University 45
Glostrup University Hospital 46
Clinical Trial Overview of Glostrup University Hospital 46
Greater Houston Retina Research 47
Clinical Trial Overview of Greater Houston Retina Research 47
Het Oogziekenhuis Rotterdam 48
Clinical Trial Overview of Het Oogziekenhuis Rotterdam 48
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 49
Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 49
Five Key Clinical Profiles 50
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99

List of Tables
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2015* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 30
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 31
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 32
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 34
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid Atlantic Retina, 2015* 35
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaguar Holding Company II, 2015* 36
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2015* 37
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2015* 38
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015* 39
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 40
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Banco de Olhos de Sorocaba, 2015* 41
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Intercommunal Creteil, 2015* 42
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 43
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eye Laser Surgery Center, 2015* 44
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Gazi University, 2015* 45
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2015* 46
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Greater Houston Retina Research, 2015* 47
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015* 48
Central Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, 2015* 49

List of Figures
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 97

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +